Response 529524830

Back to Response listing

Introduction

1. Which best describes you?

Please select one item
(Required)
I am responding as an individual
I am responding on behalf of an organisation/institution

2. What is your name?

(Required)
Mark Bartlett

3. What is the name of your organisation?

Uniting Medically Supervised Injecting Centre

4. Can we publish your response?

Please select one item
(Required)
Yes
Yes, but keep my name private
No

Draft Terms of Reference Two

2. Examine the consumer experience, focusing on equity of access and affordability of ODT medicines across the different models of delivery. This will include consideration of access to ODT for at risk population groups including people living in rural and remote areas and Aboriginal and Torres Strait Islander peoples

Strongly agree that 'affordability' is a major consideration for consumers.

Would also suggest that the TOR explicitly include ‘homeless people’ as a risk population